je.st
news
Tag: results announces
Melcor Reports First Quarter Results and Announces 12% Increase to Semi-Annual Dividend
2014-05-10 01:49:46| Chemicals - Topix.net
Melcor Developments Ltd. , an Alberta-based real estate development and asset management company, today reported results for the quarter ended March 31, 2014.
Tags: to
results
increase
reports
Trinidad Drilling (TDG) Announces Quarterly Earnings Results, Misses Expectations By $0.04 EPS
2014-05-09 17:37:44| Logistics - Topix.net
Trinidad Drilling announced its earnings results on Friday. The company reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.24 by $0.04, Stock Ratings Network reports.
Tags: results
expectations
quarterly
earnings
PFSweb (PFSW) Announces Quarterly Results
2014-05-07 22:41:53| Logistics - Topix.net
PFSweb posted its quarterly earnings results on Wednesday. The company reported EPS for the quarter, beating the Thomson Reuters consensus estimate of by $0.08, Analyst Ratings.Net reports.
Tags: results
quarterly
announces
quarterly results
Maple Leaf Foods Inc. Announces Results of Vote for Election of Directors
2014-05-03 13:46:53| Food - Topix.net
Each of the directors listed as nominees in the management proxy circular dated were elected directors of the Corporation until the next Annual Meeting.
Tags: of
results
vote
directors
Merck Announces First-Quarter 2014 Financial Results
2014-04-29 13:00:00| Merck.com - Financial News
Dateline City: WHITEHOUSE STATION, N.J. First-Quarter 2014 Non-GAAP EPS of $0.88, Excluding Certain Items; GAAP EPS of $0.57; Confirms 2014 Full-Year Non-GAAP EPS Target of $3.35 to $3.53, Excluding Certain Items; GAAP EPS Range of $2.15 to $2.47 Worldwide Sales were $10.3 Billion, a Decrease of 4 Percent, Reflecting Unfavorable Impact of Patent Expiries and a 2 Percent Unfavorable Impact from Foreign Exchange Strategic Initiatives Drove Cost Reductions and Portfolio Divestitures, Generating First-Quarter 2014 Benefits Sales of REMICADE, SIMPONI and ISENTRESS, as well as Diabetes and Vaccines Franchises Grew FDA Approved GRASTEK and RAGWITEK Sublingual Allergen Extract Immunotherapy Tablets and Accepted Filings for V503 and Suvorexant; Company Announced Progress in Key Clinical Programs Including HCV and HIV Repurchased $7.5 Billion of Common Stock Over Previous 12 Months as Part of Ongoing Share Repurchase Program WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2014. Language: English Contact: MerckMedia:Steve Cragle, 908-423-3461Lainie Keller, 908-423-4187orInvestors:Joe Romanelli, 908-423-5185Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Sites : [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] next »